Speech-Language Pathologists in Mancos, CO Accepting Medicare

4 Speech-Language Pathologists found. Showing 1 - 4

Bree Weinstein, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 211 E 3rd Ave, Mancos, CO 81328 Phone: 970-533-9031

Deborah J Wise Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 35811 Road P.6, Mancos, CO 81328 Phone: 970-394-0090

Dr. Christina Boover Lawrence, AU.D., CCC-A/SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 111 N Main St, Mancos, CO 81328 Phone: 970-459-1179

Mr. Nicholas Fredrick Lawrence Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 515 Grand Ave, Ste E, Mancos, CO 81328 Phone: 970-459-1179

News Archive

Endo enters into definitive agreement to acquire Grupo Farmaceutico Somar

Endo International plc today announced it has entered into a definitive agreement under which Endo will acquire Grupo Farmaceutico Somar, a leading privately-owned specialty pharmaceuticals company based in Mexico City, Mexico, for cash consideration. Endo expects the transaction to be immediately accretive to adjusted earnings per share.

Patients with postoperative delirium more likely to suffer dementia

Delirium is common in elderly hospitalized patients, affecting an estimated 14 - 56% of patients. It frequently manifests as a sudden change in behavior, with patients suffering acute confusion, inattention, disorganized thinking and fluctuating mental status.

Regis Technologies' 4-Aminopyridine manufacturing facility receives FDA's EIR and PAI approval

Regis Technologies, Inc., a leading provider of cGMP and non-GMP synthesis and separations services for active pharmaceutical ingredients (APIs) and intermediates, announced it has received an Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (FDA) stating that Regis passed the FDA's pre-approval inspection (PAI) for its manufacture of 4-Aminopyridine the active ingredient in Ampyra™.

Proteomic profiling shown more accurate than traditional biomarkers in identifying liver cancer

As the incidence of liver cancer continues to grow - fueled in large part, by rising rates of hepatitis C infections - so too does the need for tests to help diagnose the disease at an earlier stage.

Read more Medical News

› Verified 1 days ago